Kirby Institute, Seminar Room, Level 6, Wallace Wurth Building
Corner of High Street & Botany Street, Kensington NSW
Abstract
Vaccines against COVID-19 are probably one of the most valuable categories of vaccines ever developed. However, vaccine supply and financial constraints have forced national, regional and global decision makers into hard decisions about the best way to use these vaccines. This talk describes some of the work to assess their health impact and economic value, focusing on the way key insights in immunology, epidemiology and health economics were used to answer questions such as: Who should get the vaccines first? Is it ever better not to vaccinate? What will happen next?
 |
Professor Mark Jit Mark Jit is professor of vaccine epidemiology and head of the Department of Infectious Disease Epidemiology at the London School of Hygiene & Tropical Medicine (LSHTM), as well as visiting professor at the School of Public Health, University of Hong Kong. His research group focuses on epidemiological and economic modelling of vaccines to support evidence-based public health decision making. |
Opinions expressed by individuals at this event are solely of those of the individual/s and do not necessarily represent the views or opinions of the Kirby Institute or UNSW.
